Brief review of published alprazolam clinical studies.

Abstract

The clinical efficacy of alprazolam has been evaluated in both anxiety states and depressive disorders. In anxiety neurosis, studies have been conducted vs placebo and/or other benzodiazepine tranquilizers. Reports, to date, with regard to panic/phobia disorders have been limited to open-label studies and a single report from a placebo-controlled study. In depression, both open-label and double-blind studies (vs tricyclic antidepressants) have been published.

• Authors: R N Straw
• Journal: British journal of clinical pharmacology (Br J Clin Pharmacol) Vol. 19 Suppl 1 Pg. 57S-59S ( 1985) ISSN: 0306-5251 [Print] England
• PMID: 2859879 (Publication Type: Clinical Trial, Journal Article, Review)

Chemical References

• Anti-Anxiety Agents
• Benzodiazepines
• Alprazolam

Topics

• Alprazolam
• Anti-Anxiety Agents (therapeutic use)
• Anxiety (drug therapy)
• Benzodiazepines (therapeutic use)
• Clinical Trials as Topic
• Depression (drug therapy)
• Humans